ABOUT
Aims and Scope
About the KJM
General Information
Editorial Board
Best Pracitce
Open Access
BROWSE ARTICLES
All issues
Accepted Articles
Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
EDITORIAL POLICY
Research and Publication Ethics
Peer Review Policy
Preprints Policy
Advertising Policy
Data archiving Policy
Data sharing Policy
FOR CONTRIBUTORS
Instructions for Authors
Copyright Transfer Agreements
Article-processing Charge
E-Submission
Search
Close
PDF
Share
Facebook
Twitter
Google
LinkedIn
Metrics
Review
Korean J Med.
2003;65(1):162-163.
(Docetaxel/Capecitabine combination is an effective frontline chemotherapy in metastatic breast cancer(MBC))
, , ,
Hong Gi Lee
,
Jae Jin Lee
,
Jae Won Kim
,
Jung Sil Ro
